Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Rheumatoid arthritis tied to higher risk of bone fractures

04 Oct 2017

Both males and females with rheumatoid arthritis (RA) suffer from significantly higher risks of bone fracture than those without RA, according to a new meta-analysis. Specifically, the risks of hip and vertebral fractures are elevated in RA patients.

“Our study concludes that RA is a risk factor for bone fracture in men and women, with a comparable risk of fracture at the hip and vertebral. Patients with RA are to be monitored more closely to control bone loss and prevent fracture,” said researchers.

The meta-analysis included 13 studies, of which nine scored eight in the Newcastle-Ottawa Scale (NOS), two scored seven and the other two scored six. Overall, the studies were considered to have high methodological quality.

In the meta-analysis, patients with RA showed a significantly higher risk of getting a bone fracture compared to those without RA (risk ratio [RR], 2.25; 95 percent CI, 1.76 to 2.87; p=0.000). The analysis showed significant heterogeneity (p<0.0001) and thus warranted subgroup analyses.

Dividing the subjects by sex showed that both males (RR, 1.87; 1.48 to 2.37) and females (RR, 1.99; 1.58 to 2.50) with RA have higher bone fracture risks than their non-RA counterparts.

Pooled data from seven studies showed that RA was significantly associated with the risk of vertebral fractures (RR, 2.93; 2.25 to 3.83). Similarly, the seven studies that focused on hip fractures revealed a significant and positive correlation between RA and risk of hip fractures (RR, 2.41; 1.83 to 3.17).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 19 May 2018
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
2 days ago
Patients with inflammatory bowel disease are at increased risk of developing acute myocardial infarction (AMI) or heart failure, although the prevalence of traditional risk factors for such cardiovascular disorders appears to be low, as reported in a recent study.
3 days ago
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.